- Provides superior fluid retention3, *
- Helps protect periwound skin and reduce maceration1, 2
- Provides a bacterial and viral barrier against external contaminants**
* in vitro testing comparing Versiva® XCTM dressing to leading Foam dressings
** provided the dressing remains intact and without leakage
- Minimises pain during wear and at dressing removal1
- Designed to be skin-friendly.
- Highly flexible, conformable and can be cut, enabling application in awkward areas
- Low-profile with tapered edges for use under compression
- Excellent ease of application and removal
- Up to seven days’ wear time
* Please see package insert for complete instructions for use
Versiva® XCTM dressing on leg ulcers demonstrated a 50% decrease in mean wound size from baseline to final evaluation and clinicians reported healing or improvement in 89% of ulcers.1 *
In a prospective, noncomparative 4-week clinical study of 46 patients, 63% of patients had exuding leg ulcers for at least 6 months and 43% ofpatients had exuding leg ulcers for over 12 months
This study was funded by ConvaTec Inc.
Versiva® XCTM dressing on pressure ulcers was reported to heal/improve 61% of the ulcers and protection of the surrounding skin was rated as “good” or “excellent” in 79% of patients at final evaluation.2†
In a prospective, noncomparative 4-week clinical study of 23 patients with an average pressure ulcer duration of one year
This study was funded by ConvaTec Inc.
* in a protocol of care that included Versiva® XCTM dressing with compression and concomitant medications
† in a protocol of care that included Versiva® XCTM dressing, pressure reducing/relieving devices were mandatory